Anti‐vascular endothelial growth factor for neovascular glaucoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Neovascular Glaucoma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438848/all/Interventions_for_improving_adherence_to_iron_chelation_therapy_in_people_with_sickle_cell_disease_or_thalassaemia:_Cochrane_systematic_review. Accessed 23 April 2024.
Anti‐vascular endothelial growth factor for neovascular glaucoma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/all/Interventions_for_improving_adherence_to_iron_chelation_therapy_in_people_with_sickle_cell_disease_or_thalassaemia:_Cochrane_systematic_review. Accessed April 23, 2024.
Anti‐vascular endothelial growth factor for neovascular glaucoma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/all/Interventions_for_improving_adherence_to_iron_chelation_therapy_in_people_with_sickle_cell_disease_or_thalassaemia:_Cochrane_systematic_review
Anti‐vascular Endothelial Growth Factor for Neovascular Glaucoma [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/all/Interventions_for_improving_adherence_to_iron_chelation_therapy_in_people_with_sickle_cell_disease_or_thalassaemia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for neovascular glaucoma
ID - 438848
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438848/all/Interventions_for_improving_adherence_to_iron_chelation_therapy_in_people_with_sickle_cell_disease_or_thalassaemia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -